Nonductal neoplasms of the pancreas

Modern Pathology

Volumn 20, Issue 1, 2007, Pages 94-112

  Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acinar; Endocrine; Pancreas; Pancreatoblastoma; Solid pseudopapillary

Indexed keywords

ACINAR CELL CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL FEATURE; ENDOCRINE TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, PAPILLARY; ADENOMA, ISLET CELL; CARCINOMA, ACINAR CELL; CARCINOMA, ISLET CELL; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34248385189     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800686     Document Type: Article

References (201)

1. Heitz PU, Komminoth P, Perren A, et al. Pancreatic endocrine tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds). Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon, 2004, pp 177-182.
2. Klimstra DS, Perren A, Oberg K, et al. Pancreatic endocrine tumors: non-functioning tumours and microadenomas. In: DeLellis RA, Lloyd R, Heitz PU, Eng C (eds). Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon, 2004, pp 201-204.
3. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991;36:933-942.
4. Solcia E, Capella C, Kloppel G. Atlas of Tumor Pathology. Fascicle 20, Third Series. Armed Forces Institute of Pathology: Washington, DC, 1997.
5. Kloppel G, Willemer S, Stamm B, et al. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer 1986;57: 1824-1832.
6. Stabile BE, Morrow DJ, Passaro E. Jr. The gastrinoma triangle: operative implications. Am J Surg 1984;147: 25-31.
7. Tanaka T, Mori H, Williams GM. Atypical and neoplastic acinar cell lesions of the pancreas in an autopsy study of Japanese patients. Cancer 1988;61: 2278-2285.
8. Bartow SA, Mukai K, Rosai J. Pseudoneoplastic proliferation of endocrine cells in pancreatic fibrosis. Cancer 1981;47:2627-2633.
9. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20: 2633-2642.
10. Mukai K, Grotting JC, Greider MH, et al. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 1982;6: 387-399.
11. Larsson LI, Schwartz T, Lundqvist G, et al. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol 1976;85:675-684.
12. Tomita T, Kimmel JR, Friesen SR, et al. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations. Cancer 1985;56:1649-1657.
13. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Conneticut. Gastroenterology 1968;55: 677-686.
14. Clark ES, Carney JA. Pancreatic islet cell tumor associated with Cushing’s syndrome. Am J Surg Pathol 1984;8:917-924.
15. Doppman JL, Nieman LK, Cutler GB, Jr. et al. Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant? Radiology 1994; 190:59-64.
16. Gordon DL, Lo MC, Schwartz MA. Carcinoid of the pancreas. Am J Med 1971;51:412-415.
17. Heitz PU, Kasper M, Polak JM, et al. Pancreatic endocrine tumors. Hum Pathol 1982;13:263-271.
18. Kent RB, III, van Heerden JA, Weiland LH. Nonfunctioning islet cell tumors. Ann Surg 1981;193:185-190.
19. Le Bodic MF, Heymann MF, Lecomte M, et al. Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I. Am J Surg Pathol 1996;20:1378-1384.
20. Gumbs AA, Moore PS, Falconi M, et al. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002;81: 45-53; discussion 4.
21. Libutti SK, Choyke PL, Bartlett DL, et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 1998;124:1153-1159.
22. Hoang MP, Hruban RH, Albores-Saavedra J. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease. Am J Surg Pathol 2001;25:602-609.
23. Ligneau B, Lombard-Bohas C, Partensky C, et al. Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol 2001;25:752-760.
24. Kloppel G, Heitz PU, Capella C, et al. Endocrine tumours of the pancreas. In: Solicia E, Kloppel G, Sobin LH (eds). Histological Typing of Endocrine Tumours. Sprigner-Verlag: Heidelberg, 2000, pp 56-60.
25. Westermark P, Wernstedt C, Wilander E, et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986;140: 827-831.
26. Hussain S, Arwini A, Chetty R, et al. Oncocytic pancreatic endocrine neoplasms: a clinicopathologic and immunohistochemical analysis of 21 cases. Mod Pathol 2005;18:279A.
27. Carstens PH, Cressman FK Jr. Malignant oncocytic carcinoid of the pancreas. Ultrastruct Pathol 1989;13: 69-75.
28. Gotchall J, Traweek ST, Stenzel P. Benign oncocytic endocrine tumor of the pancreas in a patient with polyarteritis nodosa. Hum Pathol 1987;18:967-969.
29. Pacchioni D, Papotti M, Macri L, et al. Pancreatic oncocytic endocrine tumors. Cytologic features of two cases. Acta Cytol 1996;40:742-746.
30. Zee SY, Hochwald SN, Conlon KC, et al. Pleomorphic pancreatic endocrine neoplasms: a variant commonly confused with adenocarcinoma. Am J Surg Pathol 2005;29:1194-1200.
31. Deshpande V, Selig MK, Nielsen GP, et al. Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms. Am J Surg Pathol 2003;27:461-468.
32. Reid JD, Yuh SL, Petrelli M, et al. Ductuloinsular tumors of the pancreas: a light, electron microscopic and immunohistochemical study. Cancer 1982;49: 908-915.
33. van Eeden S, de Leng WW, Offerhaus GJ, et al. Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol 2004;28:813-820.
34. Lloyd RV, Mervak T, Schmidt K, et al. Immunohistochemical detection of chromogranin and neuronspecific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol 1984;8:607-614.
35. Larsson LI, Grimelius L, Hakanson R, et al. Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol 1975;79:271-284.
36. Liu TH, Tseng HC, Zhu Y, et al. Insulinoma. An immunocytochemical and morphologic analysis of 95 cases. Cancer 1985;56:1420-1429.
37. Kamisawa T, Tu Y, Egawa N, et al. Ductal and acinar differentiation in pancreatic endocrine tumors. Dig Dis Sci 2002;47:2254-2261.
38. Yantiss RK, Chang HK, Farraye FA, et al. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol 2002;26:893-901.
39. Klimstra DS, Rosai J, Heffess CS. Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 1994;18:765-778.
40. Arihiro K, Inai K. Malignant islet cell tumor of the pancreas with multiple hormone production and expression of CEA and CA19-9. Report of an autopsy case. Acta Pathol Jpn 1991;41:150-157.
41. Goto A, Niki T, Terado Y, et al. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs). Histopathology 2004;45:384-392.
42. Viale G, Doglioni C, Gambacorta M, et al. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer 1992; 70:2268-2277.
43. Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27: 1124-1134.
44. Speel EJ, Richter J, Moch H, et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 1999;155:1787-1794.
45. Stumpf E, Aalto Y, Hoog A, et al. Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 2000;29:83-87.
46. Zhao J, Moch H, Scheidweiler AF, et al. Genomic imbalances in the progression of endocrine pancreatic tumors. Genes Chromosomes Cancer 2001;32: 364-372.
47. Asteria C, Anagni M, Fugazzola L, et al. MEN1 gene mutations are a rare event in patients with sporadic neuroendocrine tumors. Eur J Intern Med 2002;13: 319-323.
48. Cupisti K, Hoppner W, Dotzenrath C, et al. Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest 2000;30:325-329.
49. Gortz B, Roth J, Krahenmann A, et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 1999;154:429-436.
50. Hessman O, Lindberg D, Einarsson A, et al. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 1999;26:258-264.
51. Komminoth P. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN. Diagn Mol Pathol 1999;8:107-112.
52. Moore PS, Missiaglia E, Antonello D, et al. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 2001;32:177-181.
53. Moore PS, Orlandini S, Zamboni G, et al. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 2001;84:253-262.
54. Shan L, Nakamura Y, Nakamura M, et al. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 1998;78:471-475.
55. Wang EH, Ebrahimi SA, Wu AY, et al. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 1998;58:4417-4420.
56. Zhuang Z, Vortmeyer AO, Pack S, et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 1997;57:4682-4686.
57. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 1998; 153:223-231.
58. Chung DC, Smith AP, Louis DN, et al. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997;100:404-410.
59. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-1560.
60. House MG, Herman JG, Guo MZ, et al. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 2003; 238:423-431; discussion 31-32.
61. Muscarella P, Melvin WS, Fisher WE, et al. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 1998;58:237-240.
62. Serrano J, Goebel SU, Peghini PL, et al. Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. J Clin Endocrinol Metab 2000;85: 4146-4156.
63. Perren A, Roth J, Muletta-Feurer S, et al. Clonal analysis of sporadic pancreatic endocrine tumours. J Pathol 1998;186:363-371.
64. Brentjens R, Saltz L. Islet cell tumors of the pancreas: the medical oncologist’s perspective. Surg Clin North Am 2001;81:527-542.
65. Dial PF, Braasch JW, Rossi RL, et al. Management of nonfunctioning islet cell tumors of the pancreas. Surg Clin North Am 1985;65:291-299.
66. Eckhauser FE, Cheung PS, Vinik AI, et al. Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery 1986;100:978-988.
67. Liu TH, Zhu Y, Cui QC, et al. Nonfunctioning pancreatic endocrine tumors. An immunohistochemical and electron microscopic analysis of 26 cases. Pathol Res Pract 1992;188:191-198.
68. Venkatesh S, Ordonez NG, Ajani J, et al. Islet cell carcinoma of the pancreas. A study of 98 patients. Cancer 1990;65:354-357.
69. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996;429:323-333.
70. Bottger T, Seidl C, Seifert JK, et al. Value of quantitative DNA analysis in endocrine tumors of the pancreas. Oncology 1997;54:318-323.
71. Kenny BD, Sloan JM, Hamilton PW, et al. The role of morphometry in predicting prognosis in pancreatic islet cell tumors. Cancer 1989;64:460-465.
72. Clarke MR, Baker EE, Weyant RJ, et al. Proliferative activity in pancreatic endocrine tumors: association with function, metastases, and survival. Endocr Pathol 1997;8:181-187.
73. Wild A, Langer P, Celik I, et al. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur J Endocrinol 2002; 147:507-513.
74. Rigaud G, Missiaglia E, Moore PS, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 2001;61:285-292.
75. Imam H, Eriksson B, Oberg K. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours. Ann Oncol 2000;11: 295-300.
76. Komminoth P, Seelentag WK, Saremaslani P, et al. CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors. Histochem Cell Biol 1996;106:551-562.
77. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004;28:1145-1153.
78. Klimstra DS, Heffess CS, Oertel JE, et al. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992;16: 815-837.
79. Klimstra DS, Wenig BM, Adair CF, et al. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol 1995;19:1371-1389.
80. Ordonez NG. Pancreatic acinar cell carcinoma. Adv Anat Pathol 2001;8:144-159.
81. Pitman MB, Faquin WC. The fine-needle aspiration biopsy cytology of pancreatoblastoma. Diagn Cytopathol 2004;31:402-406.
82. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol 2000;17:66-80.
83. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor betacatenin mutations. Am J Pathol 2002;160:1361-1369.
84. Bordi C, Oberg K, Papotti M, et al. Pancreatic endocrine tumours: poorly differentiated endocrine carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds). Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon, 2004, pp 207-208.
85. Reyes CV, Wang T. Undifferentiated small cell carcinoma of the pancreas: a report of five cases. Cancer 1981;47:2500-2502.
86. Corrin B, Gilby ED, Jones NF, et al. Oat cell carcinoma of the pancreas with ectopic ACTH secretion. Cancer 1973;31:1523-1527.
87. Hobbs RD, Stewart AF, Ravin ND, et al. Hypercalcemia in small cell carcinoma of the pancreas. Cancer 1984;53:1552-1554.
88. Chetty R, Clark SP, Pitson GA. Primary small cell carcinoma of the pancreas. Pathology 1993;25: 240-242.
89. O’Connor TP, Wade TP, Sunwoo YC, et al. Small cell undifferentiated carcinoma of the pancreas. Report of a patient with tumor marker studies. Cancer 1992;70:1514-1519.
90. Nassar H, Albores-Saavedra J, Klimstra DS. Highgrade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol 2005;29: 588-594.
91. Movahedi-Lankarani S, Hruban RH, Westra WH, et al. Primitive neuroectodermal tumors of the pancreas: a report of seven cases of a rare neoplasm. Am J Surg Pathol 2002;26:1040-1047.
92. Bismar TA, Basturk O, Gerald WL, et al. Desmoplastic small cell tumor in the pancreas. Am J Surg Pathol 2004;28:808-812.
93. Klimstra DS. Cell lineage in pancreatic neoplasms. In: Sarkar FH, Dugan MC (eds). Pancreatic Cancer: Advances in Molecular Pathology, Diagnosis and Clinical Management. BioTechniques Books: Natick, 1998, pp 21-47.
94. Albores-Saavedra J. Acinar cystadenoma of the pancreas: a previously undescribed tumor. Ann Diagn Pathol 2002;6:113-115.
95. Zamboni G, Terris B, Scarpa A, et al. Acinar cell cystadenoma of the pancreas: a new entity? Am J Surg Pathol 2002;26:698-704.
96. Chatelain D, Paye F, Mourra N, et al. Unilocular acinar cell cystadenoma of the pancreas an unusual acinar cell tumor. Am J Clin Pathol 2002;118: 211-214.
97. Holen K, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas. J Clin Oncol 2002;20:4673-4678.
98. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993;143:685-698.
99. Mizuta Y, Isomoto H, Futuki Y, et al. Acinar cell carcinoma of the pancreas associated with hypoglycemia: involvement of ‘big’ insulin-like growth factor-II. J Gastroenterol 1998;33:761-765.
100. Burns WA, Matthews MJ, Hamosh M, et al. Lipasesecreting acinar cell carcinoma of the pancreas with polyarthropathy. A light and electron microscopic, histochemical, and biochemical study. Cancer 1974;33:1002-1009.
101. Klimstra DS. Acinar cell carcinoma of the pancreas. A case associated with the lipase hypersecretion syndrome. Pathol Case Rev 2001;6:121-126.
102. Radin DR, Colletti PM, Forrester DM, et al. Pancreatic acinar cell carcinoma with subcutaneous and intraosseous fat necrosis. Radiology 1986;158:67-68.
103. Kuerer H, Shim H, Pertsemlidis D, et al. Functioning pancreatic acinar cell carcinoma: immunohistochemical and ultrastructural analyses. Am J Clin Oncol 1997;20:101-107.
104. Good AE, Schnitzer B, Kawanishi H, et al. Acinar pancreatic tumor with metastatic fat necrosis: report of a case and review of rheumatic manifestations. Am J Dig Dis 1976;21:978-987.
105. Cingolani N, Shaco-Levy R, Farruggio A, et al. Alphafetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma. Hum Pathol 2000;31:938-944.
106. Itoh T, Kishi K, Tojo M, et al. Acinar cell carcinoma of the pancreas with elevated serum alphafetoprotein levels: a case report and a review of 28 cases reported in Japan. Gastroenterol Jpn 1992;27: 785-791.
107. Nojima T, Kojima T, Kato H, et al. Alpha-fetoproteinproducing acinar cell carcinoma of the pancreas. Hum Pathol 1992;23:828-830.
108. Ono J, Sakamoto H, Sakoda K, et al. Acinar cell carcinoma of the pancreas with elevated serum alphafetoprotein. Int Surg 1984;69:361-364.
109. Shimoike T, Goto M, Nakano I, et al. Acinar-islet cell carcinoma presenting as insulinoma. J Gastroenterol 1997;32:830-835.
110. Cantrell BB, Cubilla AL, Erlandson RA, et al. Acinar cell cystadenocarcinoma of human pancreas. Cancer 1981;47:410-416.
111. Colombo P, Arizzi C, Roncalli M. Acinar cell cystadenocarcinoma of the pancreas: report of rare case and review of the literature. Hum Pathol 2004;35:1568-1571.
112. Stamm B, Burger H, Hollinger A. Acinar cell cystadenocarcinoma of the pancreas. Cancer 1987;60: 2542-2547.
113. Morohoshi T, Kanda M, Horie A, et al. Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. Cancer 1987;59: 739-747.
114. Ishizaki A, Koito K, Namieno T, et al. Acinar cell carcinoma of the pancreas: a rare case of an alphafetoprotein-producing cystic tumor. Eur J Radiol 1995;21:58-60.
115. Ohike N, Kosmahl M, Kloppel G. Mixed acinarendocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 2004;445:231-235.
116. Shinagawa T, Tadokoro M, Maeyama S, et al. Alpha fetoprotein-producing acinar cell carcinoma of the pancreas showing multiple lines of differentiation. Virchows Arch 1995;426:419-423.
117. Horie A, Morohoshi T, Kloppel G. Ultrastructural comparison of pancreatoblastoma, solid cystic tumor and acinar cell carcinoma. J Clin Electron Microsc 1987;20:353-362.
118. Tucker JA, Shelburne JD, Benning TL, et al. Filamentous inclusions in acinar cell carcinoma of the pancreas. Ultrastruct Pathol 1994;18:279-286.
119. Caruso RA, Inferrera A, Tuccari G, et al. Acinar cell carcinoma of the pancreas. A histologic, immunocytochemical and ultrastructural study. Histol Histopathol 1994;9:53-58.
120. Ordonez NG, Mackay B. Acinar cell carcinoma of the pancreas. Ultrastruct Pathol 2000;24:227-241.
121. Pasquinelli G, Preda P, Martinelli GN, et al. Filamentous inclusions in nonneoplastic and neoplastic pancreas: an ultrastructural and immunogold labeling study. Ultrastruct Pathol 1995;19:495-500.
122. Toyota N, Takada T, Ammori BJ, et al. Acinar cell carcinoma of the pancreas showing finger-print-like zymogen granules by electron microscopy: immunohistochemical study. J Hepatobiliary Pancreat Surg 2000;7:102-106.
123. Moore PS, Beghelli S, Zamboni G, et al. Genetic abnormalities in pancreatic cancer. Mol Cancer 2003;2:7.
124. Longnecker DS. Molecular pathology of invasive carcinoma. Ann N Y Acad Sci 1999;880:74-82.
125. Terhune PG, Heffess CS, Longnecker DS. Only wildtype c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog 1994;10:110-114.
126. Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002;160:953-962.
127. Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol 2002;20:4673-4678.
128. Hassan MO, Gogate PA. Malignant mixed exocrineendocrine tumor of the pancreas with unusual intracytoplasmic inclusions. Ultrastruct Pathol 1993;17:483-493.
129. Cho KJ, Kim JY, Lee SS, et al. Mixed acinar-endocrine carcinoma of the pancreas—a case report. J Korean Med Sci 1996;11:188-192.
130. Frank M, Bittinger A, Rothmund M, et al. Immunohistochemical analysis and clinical course of highmalignant composite endocrine-acinar cell carcinoma: a case report. Pancreas 1998;17:210-212.
131. Muramatsu T, Kijima H, Tsuchida T, et al. Acinar-islet cell tumor of the pancreas: report of a malignant pancreatic composite tumor. J Clin Gastroenterol 2000;31:175-178.
132. Ogawa T, Isaji S, Yabana T. A case of mixed acinarendocrine carcinoma of the pancreas discovered in an asymptomatic subject. Int J Pancreatol 2000;27: 249-257.
133. Tobita K, Kijima H, Chino O, et al. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses. Anticancer Res 2001;21:2131-2134.
134. Klimstra DS, Longnecker D. Pancreatoblastoma. In: Hamilton SR, Aaltonen LA (eds). Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, 2000, pp 244-245.
135. Japanese Pancreas Society. Classification of pancreatic carcinoma, 2nd English edn. Kanehara & Co., Ltd.: Tokyo, 2003.
136. Shorter NA, Glick RD, Klimstra DS, et al. Malignant pancreatic tumors in childhood and adolescence: the Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg 2002;37:887-892.
137. Jaksic T, Yaman M, Thorner P, et al. A 20-year review of pediatric pancreatic tumors. J Pediatr Surg 1992; 27:1315-1317.
138. Cubilla AL, Fitzgerald PJ. Morphological patterns of primary nonendocrine human pancreas carcinoma. Cancer Res 1975;35:2234-2248.
139. Hoorens A, Gebhard F, Kraft K, et al. Pancreatoblastoma in an adult: its separation from acinar cell carcinoma. Virchows Arch 1994;424:485-490.
140. Horie A. Pancreatoblastoma: histopathologic criteria based upon a review of six cases. Cancer Treat Res 1982;8:159-166.
141. Horie A, Haratake J, Jimi A, et al. Pancreatoblastoma in Japan, with differential diagnosis from papillary cystic tumor (ductuloacinar adenoma) of the pancreas. Acta Pathol Jpn 1987;37:47-63.
142. Kissane JM. Pancreatoblastoma and solid and cystic papillary tumor: two tumors related to pancreatic ontogeny. Semin Diagn Pathol 1994;11:152-164.
143. Chun Y, Kim W, Park K, et al. Pancreatoblastoma. J Pediatr Surg 1997;32:1612-1615.
144. Dhebri AR, Connor S, Campbell F, et al. Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology 2004;4:441-451; discussion 52-3.
145. Dunn JL, Longnecker DS. Pancreatoblastoma in an older adult. Arch Pathol Lab Med 1995;119: 547-551.
146. Levey JM, Banner BF. Adult pancreatoblastoma: a case report and review of the literature. Am J Gastroenterol 1996;91:1841-1844.
147. Drut R, Jones MC. Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association. Pediatr Pathol 1988;8:331-339.
148. Kerr NJ, Chun YH, Yun K, et al. Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression. Med Pediatr Oncol 2002;39:52-54.
149. Koh TH, Cooper JE, Newman CL, et al. Pancreatoblastoma in a neonate with Wiedemann-Beckwith syndrome. Eur J Pediatr 1986;145:435-438.
150. Potts SR, Brown S, O’Hara MD. Pancreoblastoma in a neonate associated with Beckwith-Wiedemann syndrome. Z Kinderchir 1986;41:56-57.
151. Abraham SC, Wu TT, Klimstra DS, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 2001; 159:1619-1627.
152. Buchino JJ, Castello FM, Nagaraj HS. Pancreatoblastoma. A histochemical and ultrastructural analysis. Cancer 1984;53:963-969.
153. Morohoshi T, Sagawa F, Mitsuya T. Pancreatoblastoma with marked elevation of serum alpha-fetoprotein. An autopsy case report with immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1990;416:265-270.
154. Ogawa B, Okinaga K, Obana K, et al. Pancreatoblastoma treated by delayed operation after effective chemotherapy. J Pediatr Surg 2000;35: 1663-1665.
155. Ohaki Y, Misugi K, Fukuda J, et al. Immunohistochemical study of pancreatoblastoma. Acta Pathol Jpn 1987;37:1581-1590.
156. Iseki M, Suzuki T, Koizumi Y, et al. Alpha-fetoprotein-producing pancreatoblastoma. A case report. Cancer 1986;57:1833-1835.
157. Chan MH, Shing MM, Poon TC, et al. Alphafetoprotein variants in a case of pancreatoblastoma. Ann Clin Biochem 2000;37(Part 5):681-685.
158. Henke AC, Kelley CM, Jensen CS, et al. Fine-needle aspiration cytology of pancreatoblastoma. Diagn Cytopathol 2001;25:118-121.
159. Kawamoto K, Matsuo T, Jubashi T, et al. Primary pancreatic carcinoma in childhood. Pancreatoblastoma. Acta Pathol Jpn 1985;35:137-143.
160. Nishimata S, Kato K, Tanaka M, et al. Expression pattern of keratin subclasses in pancreatoblastoma with special emphasis on squamoid corpuscles. Pathol Int 2005;55:297-302.
161. Silverman JF, Holbrook CT, Pories WJ, et al. Fine needle aspiration cytology of pancreatoblastoma with immunocytochemical and ultrastructural studies. Acta Cytol 1990;34:632-640.
162. Tanaka Y, Kato K, Notohara K, et al. Significance of aberrant (cytoplasmic/nuclear) expression of betacatenin in pancreatoblastoma. J Pathol 2003;199: 185-190.
163. Palosaari D, Clayton F, Seaman J. Pancreatoblastoma in an adult. Arch Pathol Lab Med 1986;110: 650-652.
164. Vannier JP, Flamant F, Hemet J, et al. Pancreatoblastoma: response to chemotherapy. Med Pediatr Oncol 1991;19:187-191.
165. Vossen S, Goretzki PE, Goebel U, et al. Therapeutic management of rare malignant pancreatic tumors in children. World J Surg 1998;22:879-882.
166. Murakami T, Ueki K, Kawakami H, et al. Pancreatoblastoma: case report and review of treatment in the literature. Med Pediatr Oncol 1996;27:193-197.
167. Griffin BR, Wisbeck WM, Schaller RT, et al. Radiotherapy for locally recurrent infantile pancreatic carcinoma (pancreatoblastoma). Cancer 1987;60: 1734-1736.
168. Kloppel G, Luttges J, Klimstra DS, et al. Solidpseudopapillary neoplasm. In: Hamilton SR, Aaltonen LA (eds). World Heath Organization Classification of Tumours. Pathology and Genetic of Tumours of the Digestive System. IARC Press: Lyon, 2000, pp 246-248.
169. Martin RC, Klimstra DS, Brennan MF, et al. Solidpseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol 2002;9:35-40.
170. Lam KY, Lo CY, Fan ST. Pancreatic solid-cysticpapillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg 1999;23:1045-1050.
171. Buetow PC, Buck JL, Pantongrag-Brown L, et al. Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases. Radiology 1996;199:707-711.
172. Matsunou H, Konishi F, Yamamichi N, et al. Solid, infiltrating variety of papillary cystic neoplasm of the pancreas. Cancer 1990;65:2747-2757.
173. Yamaguchi K, Miyagahara T, Tsuneyoshi M, et al. Papillary cystic tumor of the pancreas: an immunohistochemical and ultrastructural study of 14 patients. Jpn J Clin Oncol 1989;19:102-111.
174. Panieri E, Krige JE, Bornman PC, et al. Operative management of papillary cystic neoplasms of the pancreas. J Am Coll Surg 1998;186:319-324.
175. Mao C, Guvendi M, Domenico DR, et al. Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world’s literature. Surgery 1995;118:821-828.
176. Jeng LB, Chen MF, Tang RP. Solid and papillary neoplasm of the pancreas. Emphasis on surgical treatment. Arch Surg 1993;128:433-436.
177. Duff P, Greene VP. Pregnancy complicated by solidpapillary epithelial tumor of the pancreas, pulmonary embolism, and pulmonary embolectomy. Am J Obstet Gynecol 1985;152:80-81.
178. Stommer P, Kraus J, Stolte M, et al. Solid and cystic pancreatic tumors. Clinical, histochemical, and electron microscopic features in ten cases. Cancer 1991;67:1635-1641.
179. Lieber MR, Lack EE, Roberts Jr JR, et al. Solid and papillary epithelial neoplasm of the pancreas. An ultrastructural and immunocytochemical study of six cases. Am J Surg Pathol 1987;11:85-93.
180. Kloppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 2001;1:648-655.
181. Pettinato G, Manivel JC, Ravetto C, et al. Papillary cystic tumor of the pancreas. A clinicopathologic study of 20 cases with cytologic, immunohistochemical, ultrastructural, and flow cytometric observations, and a review of the literature. Am J Clin Pathol 1992;98:478-488.
182. Kosmahl M, Seada LS, Janig U, et al. Solid-pseudopapillary tumor of the pancreas: its origin revisited. Virchows Arch 2000;436:473-480.
183. Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol 2005;29:512-519.
184. Balercia G, Zamboni G, Bogina G, et al. Solid-cystic tumor of the pancreas. An extensive ultrastructural study of fourteen cases. J Submicrosc Cytol Pathol 1995;27:331-340.
185. Miettinen M, Partanen S, Fraki O, et al. Papillary cystic tumor of the pancreas. An analysis of cellular differentiation by electron microscopy and immunohistochemistry. Am J Surg Pathol 1987;11: 855-865.
186. Lee WY, Tzeng CC, Chen RM, et al. Papillary cystic tumors of the pancreas: assessment of malignant potential by analysis of progesterone receptor, flow cytometry, and ras oncogene mutation. Anticancer Res 1997;17:2587-2591.
187. Notohara K, Hamazaki S, Tsukayama C, et al. Solidpseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol 2000;24:1361-1371.
188. Zamboni G, Bonetti F, Scarpa A, et al. Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases. Virchows Arch A Pathol Anat Histopathol 1993;423:425-431.
189. Tanaka Y, Kato K, Notohara K, et al. Frequent betacatenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001;61:8401-8404.
190. Muller-Hocker J, Zietz CH, Sendelhofert A. Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas. Mod Pathol 2001;14:47-53.
191. Nishihara K, Nagoshi M, Tsuneyoshi M, et al. Papillary cystic tumors of the pancreas. Assessment of their malignant potential. Cancer 1993;71:82-92.
192. Ueda N, Nagakawa T, Ohta T, et al. Clinicopathological studies on solid and cystic tumors of the pancreas. Gastroenterol Jpn 1991;26:497-502.
193. Matsunou H, Konishi F. Papillary-cystic neoplasm of the pancreas. A clinicopathologic study concerning the tumor aging and malignancy of nine cases. Cancer 1990;65:283-291.
194. Hamoudi AB, Misugi K, Grosfeld JL, et al. Papillary epithelial neoplasm of pancreas in a child. Report of a case with electron microscopy. Cancer 1970;26: 1126-1134.
195. Jorgensen LJ, Hansen AB, Burcharth F, et al. Solid and papillary neoplasm of the pancreas. Ultrastruct Pathol 1992;16:659-666.
196. Yamaue H, Tanimura H, Shono Y, et al. Solid and cystic tumor of the pancreas: clinicopathologic and genetic studies of four cases. Int J Pancreatol 2000;27:69-76.
197. Flejou JF, Boulange B, Bernades P, et al. p53 protein expression and DNA ploidy in cystic tumors of the pancreas. Pancreas 1996;13:247-252.
198. Bartsch D, Bastian D, Barth P, et al. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg 1998;228:79-86.
199. Horisawa M, Niinomi N, Sato T, et al. Frantz’s tumor (solid and cystic tumor of the pancreas) with liver metastasis: successful treatment and long-term follow-up. J Pediatr Surg 1995;30:724-726.
200. Saiura A, Umekita N, Matsui Y, et al. Successful surgical resection of solid cystic tumor of the pancreas with multiple liver metastases and a tumor thrombus in the portal vein. Hepatogastroenterology 2000;47:887-889.
201. Yoon DY, Hines OJ, Bilchik AJ, et al. Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure. Am Surg 2001;67: 1195-1199.